Myocardial lipid metabolism in compensated and advanced stages of heart failure: Evaluation by canine pacing model with BMIPP

Journal of Nuclear Medicine

Volumn 42, Issue 1, 2001, Pages 124-129

  Kataoka, K ^a   Nohara, R ^a   Hosokawa, R ^a   Hirai, T ^a   Okuda, K ^a   Li Guang, C ^a   Fujibayashi, Y ^a   Fujita, M ^a   Konishi, J ^a   Sasayama, S ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

123I BMIPP; Myocardial fatty acid metabolism; Pacing induced heart failure

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; CATECHOLAMINE; FATTY ACID; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; FATTY ACID OXIDATION; HEART FAILURE; HEART HEMODYNAMICS; HEART MUSCLE METABOLISM; HEART VENTRICLE PACING; ISOTOPE LABELING; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CARDIAC PACING, ARTIFICIAL; DOGS; FATTY ACIDS; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; IODINE RADIOISOTOPES; IODOBENZENES; LIPID METABOLISM; MALE; MYOCARDIUM; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0035138612     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Myocardial utilization of carbohydrates and lipids
2. Defective Iipid metabolism in the failing heart
3. Energy metabolism of the heart: From basic concepts to clinical applications
4. Myocardial lipid turnover in dilated cardiomyopathy: A dual in vivo tracer approach
5. Iodine-123-labeled fatty acids for myocardial single-photon emission tomography: Current status and future perspectives
6. Basic studies on I-123-β-methyl-piodophenylpentadecanoic acid (BMIPP) for myocardial functional diagnosis: Effect of beta-oxidation inhibitor
7. Metabolism and kinetics of iodine-123-BMIPP in canine myocardium
8. Metabolic fate of iodine-123-BMIPP in canine myocardium after administration of etomoxir
9. Evaluation of myocardial viability with iodine-123-BMIPP in a canine model
10. Myocardial kinetics of iodine-123-BMIPP in canine myocardium after regional ischemia and reperfusion: Implications for clinical SPECT
11. Effect of metabolic substrate on BMIPP metabolism in canine myocardium
12. 123I-BMIPP in a canine model with ischemia: Implications of perfusion-metabolism mismatch on SPECT images in patients with ischemic heart disease
13. Basic kinetics of 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in canine myocardium
14. The renin-angiotensin-aldosterone system, antidiuretic hormone and sympathetic nerve activity in an experimental model of congestive heart failure in the dog
15. Rapid ventricular pacing in the dog: Pathophysiologic studies of heart failure
16. Experimental congestive heart failure produced by rapid ventricular pacing in the dog: Cardiac effects
17. Left ventricular dysfunction and dilatation resulting from chronic supraventricular tachycardia
18. Evaluation of non-radioactive, colored microspheres for measurement of regional myocardial blood flow in dogs
19. Proteolipids, a new type of tissue lipoproteins
20. Medical therapy of acute myocardial infarction by application of hemodynamic subsets
21. Reversible congestive heart failure due to chronic rapid stimulation of the normal heart
22. Cardiorenal and nerurohumoral function in a canine model of early left ventricular dysfunction
23. Tachycardia-induced cardiomyopathy: A review of animal models and clinical studies
24. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart
25. Inherited cardiomyopathies
26. Sudden death prevention in patients with advanced ventricular dysfunction
27. Repolarization abnormalities, arrhythmia and sudden death in canine tachycardia-induced cardiomyopathy
28. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children